TCR2 Therapeutics Inc (NASDAQ:TCRR)
| 1.43 Delayed Data As of 3:46pm ET |  +0.08 / +5.93%Today’s Change | 0.82 Today|||52-Week Range 3.88 | +43.17% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Assets | Cash | 8.0M | 19.8M | 47.7M | -- | |
| Short Term Investment Cash | 3.9M | 11.8M | 27.9M | -- | ||
| Cash & Short Term Investments | 16.3M | 19.8M | 123.2M | -- | ||
| Receivables | Receivables | 0.00 | 0.00 | 0.00 | -- | -- |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | -- | -- |
| Current Assets | Other Current Assets | 975.0K | 892.0K | 2.3M | -- | |
| Current Assets | 17.3M | 20.7M | 125.5M | -- | ||
| Total Assets | Property, Plant and Equipment - Gross | 1.2M | 1.6M | 2.6M | -- | |
| Depreciation | -229.0K | -527.0K | -945.0K | -- | ||
| Other Assets | 0.00 | 20.0K | 2.0M | -- | ||
| Total Assets | 18.3M | 22.0M | 129.4M | -- | ||
| Liabilities | Accounts Payable | 508.0K | 427.0K | 2.7M | -- | |
| Accrued Expenses | 15.0K | 37.0K | 747.0K | -- | ||
| Other Current Liabilities | 94.0K | 118.0K | 1.1M | -- | ||
| Other Liabilities | 966.0K | 1.2M | 5.5M | -- | ||
| Total Liabilities | Other Liabilities | 0.00 | 30.0K | 434.0K | -- | |
| Total Liabilities | 966.0K | 1.3M | 5.9M | -- | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | -- | -- |
| Preferred Stock | 29.2M | 47.1M | 209.2M | -- | ||
| Common Equity | -11.9M | -26.3M | -85.7M | -- | ||
| Total Shareholder Equity | 17.3M | 20.8M | 123.5M | -- | ||
| Share Information | Common Shares Outstanding | 23.9M | 23.9M | 23.9M | -- | |
| Addtl. Info. | No data currently available for this section. | |||||
